BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12106502)

  • 1. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis.
    Nozawa K; Casiano CA; Hamel JC; Molinaro C; Fritzler MJ; Chan EK
    Arthritis Res; 2002; 4(4):R3. PubMed ID: 12106502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique and shared features of Golgi complex autoantigens.
    Nozawa K; Fritzler MJ; Chan EK
    Autoimmun Rev; 2005 Jan; 4(1):35-41. PubMed ID: 15652777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golgi fragmentation during Fas-mediated apoptosis is associated with the rapid loss of GM130.
    Walker A; Ward C; Sheldrake TA; Dransfield I; Rossi AG; Pryde JG; Haslett C
    Biochem Biophys Res Commun; 2004 Mar; 316(1):6-11. PubMed ID: 15003503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity.
    Wu X; Molinaro C; Johnson N; Casiano CA
    Arthritis Rheum; 2001 Nov; 44(11):2642-52. PubMed ID: 11710720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human autoantibodies to a novel Golgi protein golgin-67: high similarity with golgin-95/gm 130 autoantigen.
    Eystathioy T; Jakymiw A; Fujita DJ; Fritzler MJ; Chan EK
    J Autoimmun; 2000 Mar; 14(2):179-87. PubMed ID: 10677249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human autoantibodies as reagents to conserved Golgi components. Characterization of a peripheral, 230-kDa compartment-specific Golgi protein.
    Kooy J; Toh BH; Pettitt JM; Erlich R; Gleeson PA
    J Biol Chem; 1992 Oct; 267(28):20255-63. PubMed ID: 1400343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of human anti-Golgi auto-antibodies: reactivity with components from 35 to 260 kDa.
    Kooy J; Toh BH; Gleeson PA
    Immunol Cell Biol; 1994 Apr; 72(2):123-7. PubMed ID: 7515377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera.
    Nozawa K; Fritzler MJ; von Mühlen CA; Chan EK
    Arthritis Res Ther; 2004; 6(2):R95-102. PubMed ID: 15059272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies against the Golgi apparatus].
    Renier G; Carrère F; Chevailler A
    Rev Med Interne; 1994 Mar; 15(3):174-81. PubMed ID: 8059131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Golgi autoantibodies and autoantigens.
    Renier G; Rousselet MC; Carrere F; Croue A; André C; Oksman F; Chevailler A; Hurez D
    J Autoimmun; 1994 Feb; 7(1):133-43. PubMed ID: 8198699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical association of anti-golgi autoantibodies and their autoantigens.
    Hong HS; Chung WH; Hung SI; Chen MJ; Lee SH; Yang LC
    Scand J Immunol; 2004 Jan; 59(1):79-87. PubMed ID: 14723625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrogolgin--a new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections.
    Seelig HP; Schranz P; Schröter H; Wiemann C; Renz M
    J Autoimmun; 1994 Feb; 7(1):67-91. PubMed ID: 8198703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.
    Malmegrim KC; Pruijn GJ; van Venrooij WJ
    Isr Med Assoc J; 2002 Sep; 4(9):706-12. PubMed ID: 12440236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies from patients with autoimmune disease react with a cytoplasmic antigen in the Golgi apparatus.
    Fritzler MJ; Etherington J; Sokoluk C; Kinsella TD; Valencia DW
    J Immunol; 1984 Jun; 132(6):2904-8. PubMed ID: 6373921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.
    Levine JS; Koh JS
    Semin Nephrol; 1999 Jan; 19(1):34-47. PubMed ID: 9952279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis.
    Chiu R; Novikov L; Mukherjee S; Shields D
    J Cell Biol; 2002 Nov; 159(4):637-48. PubMed ID: 12438416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis.
    Renous R; Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Exp Cell Res; 2004 Jan; 292(2):332-41. PubMed ID: 14697341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis.
    Wang Y; Shnyra A; Africa C; Warholic C; McArthur C
    Arch Oral Biol; 2009 Nov; 54(11):986-96. PubMed ID: 19716548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for cell-based multiplex diagnostics of Myasthenia gravis and autoimmune encephalitis by modifying the subcellular localization of cell membrane autoantigens.
    George S; Georgi M; Roggenbuck D; Conrad K; Küpper JH
    Clin Hemorheol Microcirc; 2014; 58(1):211-28. PubMed ID: 25248352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered structure of autoantigens during apoptosis.
    Hall JC; Casciola-Rosen L; Rosen A
    Rheum Dis Clin North Am; 2004 Aug; 30(3):455-71, vii. PubMed ID: 15261336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.